CEDAR.Co.Ltd Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 2/6
CEDAR.Co.Ltd's earnings have been declining at an average annual rate of -19.8%, while the Healthcare industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 3.4% per year. CEDAR.Co.Ltd's return on equity is 13.8%, and it has net margins of 0.9%.
Key information
-19.8%
Earnings growth rate
-19.6%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 3.4% |
| Return on equity | 13.8% |
| Net Margin | 0.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Subdued Growth No Barrier To CEDAR.Co.,Ltd. (TSE:2435) With Shares Advancing 31%
Nov 08
Here's Why CEDAR.Co.Ltd (TSE:2435) Has A Meaningful Debt Burden
Nov 01CEDAR.Co.,Ltd.'s (TSE:2435) Shares Climb 35% But Its Business Is Yet to Catch Up
Sep 04CEDAR.Co.Ltd's (TSE:2435) Strong Earnings Are Of Good Quality
May 22Shareholders Are Loving CEDAR.Co.,Ltd.'s (TYO:2435) 2.0% Yield
Apr 29Is CEDAR.Co.Ltd (TYO:2435) A Risky Investment?
Feb 18
Is CEDAR.Co.,Ltd. (TYO:2435) A Smart Pick For Income Investors?
Jan 14Why CEDAR.Co.,Ltd. (TYO:2435) Looks Like A Quality Company
Dec 19Should You Use CEDAR.Co.Ltd's (TYO:2435) Statutory Earnings To Analyse It?
Nov 23Revenue & Expenses Breakdown
How CEDAR.Co.Ltd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 17,464 | 154 | 1,198 | 0 |
| 31 Mar 24 | 17,304 | 203 | 1,184 | 0 |
| 31 Dec 23 | 17,118 | 132 | 1,180 | 0 |
| 30 Sep 23 | 16,974 | 72 | 1,182 | 0 |
| 30 Jun 23 | 16,715 | -101 | 1,186 | 0 |
| 31 Mar 23 | 16,442 | -276 | 1,201 | 0 |
| 31 Dec 22 | 16,194 | -327 | 1,210 | 0 |
| 30 Sep 22 | 15,964 | -405 | 1,186 | 0 |
| 30 Jun 22 | 15,847 | -357 | 1,145 | 0 |
| 31 Mar 22 | 15,749 | -319 | 1,124 | 0 |
| 31 Dec 21 | 15,730 | -28 | 1,123 | 0 |
| 30 Sep 21 | 15,697 | 67 | 1,109 | 0 |
| 30 Jun 21 | 15,713 | 251 | 1,087 | 0 |
| 31 Mar 21 | 15,613 | 387 | 1,023 | 0 |
| 31 Dec 20 | 15,586 | 520 | 872 | 0 |
| 30 Sep 20 | 15,516 | 550 | 866 | 0 |
| 30 Jun 20 | 15,310 | 434 | 866 | 0 |
| 31 Mar 20 | 15,132 | 209 | 987 | 0 |
| 31 Dec 19 | 14,808 | -36 | 1,087 | 0 |
| 30 Sep 19 | 14,548 | -91 | 1,064 | 0 |
| 30 Jun 19 | 14,364 | -102 | 1,048 | 0 |
| 31 Mar 19 | 14,258 | 16 | 929 | 0 |
| 31 Dec 18 | 14,093 | 173 | 862 | 0 |
| 30 Sep 18 | 13,985 | 133 | 818 | 0 |
| 30 Jun 18 | 13,937 | 149 | 781 | 0 |
| 31 Mar 18 | 13,861 | 224 | 717 | 0 |
| 31 Dec 17 | 13,776 | 208 | 740 | 0 |
| 30 Sep 17 | 13,500 | 73 | 721 | 0 |
| 30 Jun 17 | 13,127 | -33 | 695 | 0 |
| 31 Mar 17 | 12,733 | -137 | 672 | 0 |
| 31 Dec 16 | 12,441 | -103 | 671 | 0 |
| 30 Sep 16 | 12,185 | 0 | 624 | 0 |
| 30 Jun 16 | 11,967 | 24 | 591 | 0 |
| 31 Mar 16 | 11,731 | 9 | 575 | 0 |
| 31 Dec 15 | 11,494 | -235 | 608 | 0 |
| 30 Sep 15 | 11,232 | -358 | 598 | 0 |
| 30 Jun 15 | 10,981 | -384 | 594 | 0 |
| 31 Mar 15 | 10,791 | -368 | 577 | 0 |
| 31 Dec 14 | 10,583 | -278 | 576 | 0 |
| 30 Sep 14 | 10,480 | -118 | 561 | 0 |
| 30 Jun 14 | 10,439 | -9 | 544 | 0 |
| 31 Mar 14 | 10,415 | 77 | 542 | 0 |
| 31 Dec 13 | 10,368 | 147 | 508 | 0 |
Quality Earnings: 2435 has a large one-off loss of ¥384.0M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 2435 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2435 has become profitable over the past 5 years, growing earnings by -19.8% per year.
Accelerating Growth: 2435 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2435 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (5.1%).
Return on Equity
High ROE: 2435's Return on Equity (13.8%) is considered low.